Kramer M, Mele F, Jovic S, Fernandez B, Jarrossay D, Low J
J Clin Invest. 2025; 135(2.
PMID: 39817450
PMC: 11735102.
DOI: 10.1172/JCI183776.
Eugster A, Lorenc A, Kotrulev M, Kamra Y, Goel M, Steinberg-Bains K
Nat Commun. 2024; 15(1):9204.
PMID: 39472557
PMC: 11522472.
DOI: 10.1038/s41467-024-53255-9.
Linsley P, Nakayama M, Balmas E, Chen J, Barahmand-Pour-Whitman F, Bansal S
Nat Commun. 2024; 15(1):4971.
PMID: 38871688
PMC: 11176301.
DOI: 10.1038/s41467-024-48833-w.
Ramirez-Valle F, Maranville J, Roy S, Plenge R
Nat Rev Drug Discov. 2024; 23(7):501-524.
PMID: 38839912
DOI: 10.1038/s41573-024-00959-8.
Srivastava N, Hu H, Peterson O, Vomund A, Stremska M, Zaman M
Immunity. 2024; 57(7):1629-1647.e8.
PMID: 38754432
PMC: 11236520.
DOI: 10.1016/j.immuni.2024.04.017.
Is the exquisite specificity of lymphocytes generated by thymic selection or due to evolution?.
De Boer R, Kesmir C, Perelson A, Borghans J
Front Immunol. 2024; 15:1266349.
PMID: 38605941
PMC: 11008227.
DOI: 10.3389/fimmu.2024.1266349.
Induction of islet autoimmunity to defective ribosomal product of the insulin gene as neoantigen after anti-cancer immunotherapy leading to autoimmune diabetes.
van Tienhoven R, Jansen D, Park M, Williams J, Larkin J, Quezada S
Front Immunol. 2024; 15:1384406.
PMID: 38596681
PMC: 11002119.
DOI: 10.3389/fimmu.2024.1384406.
Systematic immune cell dysregulation and molecular subtypes revealed by single-cell RNA-seq of subjects with type 1 diabetes.
Honardoost M, Adinatha A, Schmidt F, Ranjan B, Ghaeidamini M, Rayan N
Genome Med. 2024; 16(1):45.
PMID: 38539228
PMC: 10976681.
DOI: 10.1186/s13073-024-01300-z.
CD4+ T Cells From Individuals With Type 1 Diabetes Respond to a Novel Class of Deamidated Peptides Formed in Pancreatic Islets.
Callebaut A, Guyer P, Derua R, Buitinga M, Manganaro A, Yi X
Diabetes. 2024; 73(5):728-742.
PMID: 38387030
PMC: 11043062.
DOI: 10.2337/db23-0588.
Identification of unstable regulatory and autoreactive effector T cells that are expanded in patients with mutations.
Borna S, Lee E, Nideffer J, Ramachandran A, Wang B, Baker J
Sci Transl Med. 2023; 15(727):eadg6822.
PMID: 38117899
PMC: 11070150.
DOI: 10.1126/scitranslmed.adg6822.
The beta cell-immune cell interface in type 1 diabetes (T1D).
James E, Joglekar A, Linnemann A, Russ H, Kent S
Mol Metab. 2023; 78:101809.
PMID: 37734713
PMC: 10622886.
DOI: 10.1016/j.molmet.2023.101809.
Lung injury induces a polarized immune response by self-antigen-specific CD4 Foxp3 regulatory T cells.
Shin D, Ratnapriya S, Cashin C, Kuhn L, Rahimi R, Anthony R
Cell Rep. 2023; 42(8):112839.
PMID: 37471223
PMC: 10529088.
DOI: 10.1016/j.celrep.2023.112839.
Challenges and solutions for therapeutic TCR-based agents.
Malviya M, Aretz Z, Molvi Z, Lee J, Pierre S, Wallisch P
Immunol Rev. 2023; 320(1):58-82.
PMID: 37455333
PMC: 11141734.
DOI: 10.1111/imr.13233.
The Adaptation Model of Immunity: Signal IV Matters Most in Determining the Functional Outcomes of Immune Responses.
Manjili M
J Immunol. 2023; 210(5):521-530.
PMID: 36881868
PMC: 10000300.
DOI: 10.4049/jimmunol.2200672.
Citrullination modulates antigen processing and presentation by revealing cryptic epitopes in rheumatoid arthritis.
Curran A, Girgis A, Jang Y, Crawford J, Thomas M, Kawalerski R
Nat Commun. 2023; 14(1):1061.
PMID: 36828807
PMC: 9958131.
DOI: 10.1038/s41467-023-36620-y.
Characterizing T cell responses to enzymatically modified beta cell neo-epitopes.
Nguyen H, Arribas-Layton D, Chow I, Speake C, Kwok W, Hessner M
Front Immunol. 2023; 13:1015855.
PMID: 36703975
PMC: 9871889.
DOI: 10.3389/fimmu.2022.1015855.
Foxp3+ regulatory T cell therapy for tolerance in autoimmunity and solid organ transplantation.
Sanders J, Jeyamogan S, Mathew J, Leventhal J
Front Immunol. 2022; 13:1055466.
PMID: 36466912
PMC: 9714335.
DOI: 10.3389/fimmu.2022.1055466.
IL-2-based approaches to Treg enhancement.
Harris F, Berdugo Y, Tree T
Clin Exp Immunol. 2022; 211(2):149-163.
PMID: 36399073
PMC: 10019135.
DOI: 10.1093/cei/uxac105.
Recognition of mRNA Splice Variant and Secretory Granule Epitopes by CD4+ T Cells in Type 1 Diabetes.
Guyer P, Arribas-Layton D, Manganaro A, Speake C, Lord S, Eizirik D
Diabetes. 2022; 72(1):85-96.
PMID: 36201618
PMC: 9797322.
DOI: 10.2337/db22-0191.
Host-microbiota interactions shaping T-cell response and tolerance in type 1 diabetes.
Majumdar S, Lin Y, Bettini M
Front Immunol. 2022; 13:974178.
PMID: 36059452
PMC: 9434376.
DOI: 10.3389/fimmu.2022.974178.